Natural killer (NK) cells from killers to regulators: Distinct features between peripheral blood and decidual NK cells

American Journal of Reproductive Immunology

Volumn 58, Issue 3, 2007, Pages 280-288

  Santoni, Angela ^a   Zingoni, Alessandra ^a   Cerboni, Cristina ^a   Gismondi, Angela ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Angiogenesis; Chemokines; Cytokines; Migration; Natural killer cells; Uterine NK cells

Indexed keywords

ANGIOGENIC FACTOR; B7 ANTIGEN; CD134 ANTIGEN; CD70 ANTIGEN; CD86 ANTIGEN; CHEMOKINE; CYTOKINE;

AUTOIMMUNE DISEASE; BLOOD; CELL INTERACTION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOTOXIC LYMPHOCYTE; DECIDUA; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL; NONHUMAN; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; UTERUS;

CHEMOKINES; CYTOKINES; DECIDUA; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; PREGNANCY;

EID: 34547894748     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2007.00513.x     Document Type: Review

References (64)

1. Trinchieri G: Biology of natural killer cells. Adv Immunol 1989; 47:187-376.
2. Lanier LL: NK cell recognition. Annu Rev Immunol 2005; 23:225-227.
3. Gismondi A, Santoni A: Migration of NK cells. In Lymphocyte Trafficking in Health and Disease, R Badolato, S Sozzani (eds). Basel, Birkhauser Verlag, 2006, pp 95-112.
4. Di Santo JP, Vosshenrich CAJ: Bone marrow versus thymic pathways of natural killer cell development. Immunol Rev 2006; 214:35-46.
5. King A, Burrows T, Loke YW: Human uterine natural killer cells. Nat Immun 1996-97; 15:41-52.
6. Whitelaw PF, Croy BA: Granulated lymphocytes of pregnancy. Placenta 1996; 17:533-543.
7. Biron CA: Activation and function of natural killer cell responses during viral infection. Curr Opin Immunol 1997; 9:24-34.
8. Fogler WE, Volker K, McCormick KL, Watanabe M, Ortaldo JR, Wiltrout RH: NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction. J Immunol 1996; 156:4707-4714.
9. Moretta A: Natural killer cells and Rendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2002; 2:957-964.
10. Raulet DH, Vance RE: Self-tolerance of natural killer cells. Nat Rev Immunol 2006; 6:520-531.
11. Yokoyama WM, Kim S: Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol Rev 2006; 214:143-154.
12. Raulet DH: Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003; 3:781-790.
13. Gasser S, Orsulic S, Brown EJ, Raulet DH: The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005; 436:1186-1190.
14. Cerboni C, Zingoni A, Cippitelli M, Piccoli M, Frati L, Santoni A: Antigen-activated human T lymphocytes express cell surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK cell lysis. Blood 2007; 110:606-615.
15. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L: Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001; 19:197-223.
16. Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, Carnemolla B, Cantoni C, Grassi J, Marcenaro S, Reymond N, Vitale M, Moretta L, Lopez M, Morretta A: Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 2003; 198:557-567.
17. Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, Carson WE, Caligiuri MA: HumaA natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001; 97:3146-3151.
18. Perussia B, Loza MJ: Linear "2-0-1" lymphocyte development: hypotheses on cellular bases for immunity. Trends Immunol 2003; 24:235-241.
19. French AR, Yokoyama WM: Natural Killer cells and viral infections. Curr Opinion Immunol 2003; 15:45-51.
20. Gazzinelli RT, Hieny S, Wynn TA et al.: Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient host. Proc Natl Acad Sci USA 1993; 90:6115-6119.
21. Martin-Fontecha A, Thomsen LL, Brett S et al.: Induced recruitment of NK cells to lymph nodes provides IFN-gamma for Th1 priming. Nat Immunol 2004; 5:1260-1265.
22. Dowdell KC, Cua DJ, Kirkman E et al.: NK cells regulate CD4 response prior to antigen encounter. J Immunol 2003; 171:234-239.
23. Li MO, Wan YY, Sanjabi S et al.: Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006; 24:4-40.
24. Salazar-Mather TP, Hamilton TA, Biron CA: A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J Clin Invest 2000; 105:985-993.
25. Degli-Esposti MA, Smyth M: Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol 2005; 5:112-124.
26. Andrews DM, Scalzo AA, Yokoyama WM et al.: Functional interactions between dendritic cells and NK cells during viral infections. Nat Immunol 2002; 4:175-180.
27. Fernandez NC, Lozier A, Flament C et al.: Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate and anti-tumour immune responses in vivo. Nat Med 1999; 5:405-411.
28. Yu Y, Hagihara M, Gansuvd B et al.: Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells. J Immunol 2001; 166:1590-1600.
29. Ferlazzo G, Munz C: NK cell compartments and their activation by dendritic cells. J Immunol 2004; 172:1334-1339.
30. Fehniger TA, Cooper MA, Nuovo GJ et al.: CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: A potential new link between adaptive and innate immunity. Blood 2003; 101:3052-3057.
31. Zingoni A, Sornasse T, Cocks BG et al.: Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 L interactions. J Immunol 2004; 173:3716-3724.
32. Hanna J, Gonen-Gross T, Fitchett J et al.: Novel APC-like properties of human NK cells directly regulate T cell activation. J Clin Invest 2004; 114:1612-1623.
33. Assarsson E, Kambayashi T, Schatzle JD et al.: NK cells stimulate proliferation of T and NK cells through 2B4/CD48 interactions. J Immunol 2004; 173:174-180.
34. Westwood JA, Kelly JM, Tanner JE et al.: Novel priming of tumour specific immunity by NKG2D-triggered NK cell-mediated tumour rejection and Th1-independent CD4+ T cell pathway. J Immunol 2003; 171:757-761.
35. Maier S, Tertilt C, Chambron N et al.: Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice. Nat Med 2001; 7:557-562.
36. Uehara S, Chase CM, Kitchens WH et al.: NK cells can trigger allograft vasculopathy: The role of hybrid resistance in solid organ allograft. J Immunol 2005; 175:3424-3430.
37. Su HC, Nguyen KB, Salazar-Mather TP et al.: NK cell function restrain T cell responses during viral infections. Eur J Immunol 2001; 31:3048-3055.
38. French AR, Yokoyama WM: Natural Killer cells and autoimmunity. Arthritis Res Ther 2004; 6:8-14.
39. Shi FD, Van Kaer L: Reciprocal regulation between natural killer cells and autoreactive T cells. Nat Rev Immunol 2006; 6:751-760.
40. Zhang B, Yamamura T, Kondo T et al.: Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 1997; 186:1677-1687.
41. Madeline MF, Leach MW, Rennick DM: A role for NK cells as regulators of CD4+ T cells in a transfer model of colitis. J Immunol 1998; 161:3256-3261.
42. Schott E, Bonasio R, Ploegh H: Elimination in vivo of developing T cells by natural killer cells. J Exp Med 2003; 198:1213-1224.
43. Rabinovich BA, Li J, Shannon J, Hurren R et al.: Activated, but not resting T cells can be recognized and killed by syngeneic NK cells. J Immunol 2003; 170:3572-3576.
44. Molinero LL, Fuertes MB, Rabinovich GA et al.: Activation-induced expression of MICA on T lymphocytes involves engagement of CD3 and CD28. J Leukoc Biol 2002; 71:791-797.
45. Maasho K, Opoku-Anane J, Marusina AI et al.: NKG2D is a costimulatory receptor for human naive CD8+ T cells. J Immunol 2005; 174:4480-4484.
46. King A: Uterine leukocytes and decidualization. Hum Reprod Update 2000; 6:28-36.
47. Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, Masch R, Lockwood CJ, Schachter AD, Park PJ, Strominger JL: Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 2003; 198:1201-1212.
48. Moffett-King A: Natural killer cells and pregnancy. Nat Rev Immunol 2002; 2:656-663.
49. Kitaya K, Yasuda J, Yagi I, Tada Y, Fushiki S, Honjo H: IL-15 expression at human endometrium and decidua. Biol Reprod 2000; 63:683-687.
50. Zourbas S, Dubanchet S, Martal J, Chaouat G: Localization of pro-inflammatory cytokines at the foetomaternal interface during murine pregnancy. Clin Exp Immunol 2001; 126:519-528.
51. Keskin DB, Allan DS, Rybalov B et al.: TGFbeta promotes conversion of CD16+ peripheral blood NK cells into CD16- NK cells with similarities to decidual NK cells. Proc Natl Acad Sci U S A 2007; 104:3378-3383.
52. Hanna J, Wald O, Goldman-Wohl D, Prus D, Markel G, Gazit R, Katz G, Haimov-Kochman R, Fujii N, Yagel S et al.: CXCL12 expression by invasive trophoblasts induces the specific migration of CD16- human natural killer cells. Blood 2003; 102:1569-1577.
53. Sentman CL, Meadows SK, Wira CR, Eriksson M: Recruitment of uterine NK cells: Induction of CXC chemokine ligands 10 and 11 in human endometrium by estradiol and progesterone. J Immunol 2004; 173:6760-6766.
54. Drake PM, Gunn MD, Charo IF, Tsou C, Zhou Y, Huang LR, Fisher SJ: Reciprocal chemokine receptor and ligand expression in the human placenta: Implications for human placenta cytotrophoblast attract monocytes and CD56 bright natural killer cells via actions of monocyte inflammatory protein 1 a. J Exp Med 2001; 193:1199-1212.
55. Chantakru S, Kuziel WA, Maeda N, Croy BA: A study on the density and distribution of uterine Natural Killer cells at mid pregnancy in mice genetically-ablated for CCR2, CCR 5 and the CCR5 receptor ligand, MIP-1 alpha. J Reprod Immunol 2001; 49:33-47.
56. Drake PM, Red-Horse K, Fisher SJ: Reciprocal chemokine receptor and ligand expression in the human placenta: Implications for cytotrophoblast differentiation. Dev Dyn 2004; 229:877-885.
57. Tabiasco J, Rabot M, Aguerre-Girr M, El Costa H, Berrebi A, Parant O, Laskarin G, Juretic K, Bensussan A, Rukavina D, Le Bouteiller P: Human decidual NK cells: Unique phenotype and functional properties. Placenta 2006; 27(suppl. A):S34-S39.
58. Kopcow HD, Allan DS, Chen X, Rybalov B, Andzelm MM, Ge B, Strominger JL: Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc Natl Acad Sci USA 2005; 102:15563-15568.
59. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, Prus D, Cohen-Daniel L, Arnon TI, Manaster I, Gazit R, Yutkin V, Benharroch D, Porgador A, Keshet E, Yagel S, Mandelboim O: Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006; 12:1065-1074.
60. Dietl J, Honig A, Kammerer U, Rieger L: Natural killer cells and dendritic cells at the human feto-maternal interface: An effective cooperation? Placenta 2006; 27:341-347.
61. Leonard S, Murrant C, Tayade C, van den Heuvel M, Watering R, Croy BA: Mechanisms regulating immune cell contributions to spiral artery modification - facts and hypotheses - a review. Placenta 2006; 27(Suppl A):S40-S46.
62. Anne Croy B, van den Heuvel MJ, Borzychowski AM, Tayade C: Uterine natural killer cells: A specialized differentiation regulated by ovarian hormones. Immunol Rev 2006; 214:161-185.
63. Hiby SE, Walker JJ, O'shaughnessy KM, Redman CW, Carrington M, Trowsdale J, Moffett A: Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004; 200:957-965.
64. Saito S, Takeda Y, Sakai M, Nakabayahi M, Hayakawa S: The incidence of pre-eclampsia among couples consisting of Japanese women and Caucasian men. J Reprod Immunol 2006; 70:93-98.